HealthTech Arkansas, Kx Advisors partner to help biotherapeutics startups

by Talk Business & Politics staff ([email protected]) 421 views 

HealthTech Arkansas and Kx Advisors have partnered to provide support to the biotherapeutics startup companies participating in the BioAR Trial accelerator program, the two groups announced Thursday (Feb. 9).

Kx Advisors provides advisory services to help leading pharmaceutical, biotechnology, medical technology, digital health, and diagnostics companies fully capitalize on product opportunities, navigate the environment with greater certainty, and maximize the lifetime commercial value of their portfolios.

As part of the partnership, companies selected for the BioAR Trial cohort will participate in a virtual seminar on growth strategies presented by Kx Advisors, in addition to one-on-one follow-up sessions.

“We’re very excited to bring the formidable skills and experiences of the Kx team to bear for BioAR Trial cohort companies,” said Jeff Stinson, director of HealthTech Arkansas. “Personalized, high-level advisement on growth strategies is another example of how we add value to early-stage companies developing advanced biotherapeutics.”

“We’re thrilled to collaborate in this partnership with HealthTech Arkansas to support the advancement of innovative biotherapeutics and the hope they provide to patients, families, and their healthcare providers,” said Sean Vander Linde, Partner at Kx Advisors. “Among Kx’s strengths is our strategic advice supporting companies with clinical-stage assets. Partnerships such as these allow us to contribute to setting these organizations and their valuable innovations up for success.”

BioAR Trial was created to help biotherapeutics companies in late pre-clinical stages of development bring groundbreaking therapies to market faster, while increasing Arkansans’ access to cutting-edge clinical care and innovative medicines. This effort aligns with HealthTech Arkansas’ mission to identify and bring superior healthcare technologies to Arkansas to benefit the state’s providers.

Applications for BioAR Trial are currently open through February 28, 2023. More information and a link to the application can be found at